Skip to content
Medical AI ReportIndependent evaluations

1 shared rubric · Updated September 2026

Doximity Ask vs OpenEvidence

Doximity Ask and OpenEvidence share one scored category, clinical decision support AI. OpenEvidence scores higher in the shared category — 33–36 for clinical decision support AI out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

Reviewed by Abishek Shahi, MD · Last reviewed September 2026

Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.

Doximity Ask

Decision support

33/50

Full Doximity Ask review

OpenEvidence

Decision support

36/50

Full OpenEvidence review

Side by side

Doximity Ask and OpenEvidence, dimension by dimension

Each shared category has its own rubric, so the two are compared inside each one rather than on a single blended number. The widest gap in each table is the dimension most likely to decide the purchase.

Clinical decision support AI

3336OpenEvidence by 3

Clinical decision support AI rubric, ordered by the size of the gap. Each dimension is scored out of 10.
DimensionDoximity AskOpenEvidenceGap
Evidence groundingWhether answers carry inline citations to identifiable primary sources, whether those citations are validated against the claim they support, and how current the underlying corpus is.79-2
Corpus depth & curationBreadth and editorial quality of the underlying knowledge base, refresh cadence, and whether coverage extends beyond common presentations to rarer clinical questions.79-2
Access & eligibilityPublished pricing, free tier, credential gating such as a US NPI requirement, regional availability, and language coverage.98+1
Reasoning transparencyWhether the tool shows how it reached the answer — an inspectable reasoning trace, a ranked differential with rationale — or returns a conclusion you must take on trust.33
Workflow & EHR fitHow the tool reaches the clinician: SMART on FHIR embedding, single sign-on, mobile access, and whether querying interrupts or fits the encounter.77

Doximity Ask

Best for
US clinicians already working inside the Doximity app who want a fast, free answer without adding another login or licence.
Limitation
A feature rather than a dedicated evidence platform: a narrower corpus than the paid references, US-centric, no reasoning shown and no API.
Price
Free

OpenEvidence

Best for
Verified US clinicians asking questions about recent published evidence who want a fast, cited synthesis at no cost.
Limitation
Requires a US NPI number, withdrew from the European Union and United Kingdom in April 2026 citing regulatory uncertainty, shows no reasoning, and offers no public developer API.
Price
Free, funded by pharmaceutical advertising

The decision

Which one should you buy?

Choose Doximity Ask when

  • Decision support

    US clinicians already working inside the Doximity app who want a fast, free answer without adding another login or licence.

What it cannot do

A feature rather than a dedicated evidence platform: a narrower corpus than the paid references, US-centric, no reasoning shown and no API.

Every Doximity Ask score

Choose OpenEvidence when

  • Decision support

    Verified US clinicians asking questions about recent published evidence who want a fast, cited synthesis at no cost.

What it cannot do

Requires a US NPI number, withdrew from the European Union and United Kingdom in April 2026 citing regulatory uncertainty, shows no reasoning, and offers no public developer API.

Every OpenEvidence score

Limits

What this comparison cannot tell you

Neither tool has been benchmarked here against live patient data. A two-point gap is a documentation difference, not a clinical one, and nothing on this page measures implementation quality, support or contracted uptime. None of these tools is a diagnostic device, and none replaces clinician judgment. Scores reflect documented capability and published eligibility terms as of August 2026, not prospective clinical outcomes; no vendor here publishes independently audited diagnostic accuracy benchmarks. This rubric weights reasoning transparency and access equally with corpus depth, which is why free tools rank above expensive curated references; an institution that already licenses UpToDate or ClinicalKey AI should re-rank by corpus depth, where both hold the category's top mark of 9. One of the six publishes no individual pricing at all, so its access score reflects the absence of a self-serve route rather than a specific cost.

Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.

Common questions

Doximity Ask vs OpenEvidence: common questions

Is Doximity Ask or OpenEvidence better?

Doximity Ask and OpenEvidence share one scored category, clinical decision support AI. OpenEvidence scores higher in the shared category — 33–36 for clinical decision support AI out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

What is the biggest difference between Doximity Ask and OpenEvidence?

For clinical decision support AI the widest gap is evidence grounding: 7/10 for Doximity Ask against 9/10 for OpenEvidence. That dimension measures whether answers carry inline citations to identifiable primary sources, whether those citations are validated against the claim they support, and how current the underlying corpus is.

When should you choose Doximity Ask over OpenEvidence?

US clinicians already working inside the Doximity app who want a fast, free answer without adding another login or licence. The case against it: A feature rather than a dedicated evidence platform: a narrower corpus than the paid references, US-centric, no reasoning shown and no API.

When should you choose OpenEvidence over Doximity Ask?

OpenEvidence scores higher for clinical decision support AI. Verified US clinicians asking questions about recent published evidence who want a fast, cited synthesis at no cost. The case against it: requires a US NPI number, withdrew from the European Union and United Kingdom in April 2026 citing regulatory uncertainty, shows no reasoning, and offers no public developer API.

How do Doximity Ask and OpenEvidence compare on price?

Doximity Ask: Free OpenEvidence: Free, funded by pharmaceutical advertising Pricing comes from each vendor's published pricing page; where a vendor publishes no rate, that is recorded rather than estimated.